Avalo Therapeutics stock rises after Guggenheim initiates with Buy rating By Investing.com Avalo Therapeutics stock rises after Guggenheim initiates with Buy rating…
Avalo Reports 2024 Financial Results and Recent Business Updates WAYNE, Pa. and ROCKVILLE, Md., March 20, 2025 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical…
Avalo Therapeutics Appoints Jennifer Riley as Chief Strategy Officer WAYNE, Pa. and ROCKVILLE, Md., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical…
Avalo Reports Second Quarter 2024 Financial Results and Provides Business Updates WAYNE, Pa. and ROCKVILLE, Md., Aug. 12, 2024 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), today announced…
Avalo Reports First Quarter 2024 Financial Results and Provides Business Updates WAYNE, Pa. and ROCKVILLE, Md., May 13, 2024 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), today announced…
Avalo Therapeutics Appoints Biotech Leaders to Board of Directors WAYNE, Pa. and ROCKVILLE, Md., April 02, 2024 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX) today announced…
Avalo Therapeutics (AVTX) Surges 270% in a Week: Heres Why Avalo (AVTX) surges on adding a new pipeline drug, which has its origins at Eli Lilly. Alongside the acquisition, it…
Avalo Reports 2023 Financial Results and Provides Business Updates WAYNE, Pa. and ROCKVILLE, Md., March 29, 2024 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), today announced…